Macular Telangiectasia Type 2: Current and Emerging Diagnostic Imaging Modalities
Klinische Monatsblätter für Augenheilkunde · 01.09.2026 · 243 (09) · 901-910
DOI: 10.1055/a-2937-4106 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.09.2026. Verfasst von Chantal Dysli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Inselspital University Hospital Bern, Department of Ophthalmology, BE, Switzerland, Bern. Hauptthemen laut MEDLINE: Retinal Telangiectasis, Multimodal Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Macular telangiectasia type 2 (MacTel type 2) is a progressive neurodegenerative macular disease whose diagnosis, prognostic assessment, and longitudinal monitoring rely critically on the recognition of its characteristic clinical and imaging features. This systematic review provides a comprehensive overview of the most important diagnostic findings in MacTel type 2, encompassing both biomicroscopic clinical signs and the full spectrum of multimodal imaging modalities currently employed in clinical practice—including color fundus photography, fluorescein angiography, fundus autofluorescence, multicolor imaging, spectral-domain optical coherence tomography (OCT), and OCT angiography. For each modality, key diagnostic signs, their contribution to disease staging, and their value in monitoring disease progression are discussed. Additionally, a specific focus on emerging imaging techniques is provided with potential relevance to future diagnostic and research applications. In MacTel type 2, a multimodal imaging approach represents the most effective strategy for accurate diagnosis, reliable staging of disease severity, and meaningful prognostic assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Inselspital University Hospital Bern, Department of Ophthalmology, BE, Switzerland, Bern.
ORCID-Profile: Chantal Dysli
Zitieren
APA
Dysli, C., Sagurski, N., Ferro Desideri, L., & Zinkernagel, M. S. (2026). Macular Telangiectasia Type 2: Current and Emerging Diagnostic Imaging Modalities. Klinische Monatsblätter für Augenheilkunde, 243(09), 901-910. https://doi.org/10.1055/a-2937-4106
Vancouver
Dysli C, Sagurski N, Ferro Desideri L, Zinkernagel MS. Macular Telangiectasia Type 2: Current and Emerging Diagnostic Imaging Modalities. Klinische Monatsblätter für Augenheilkunde. 2026;243(09):901-910. doi:10.1055/a-2937-4106
BibTeX
@article{Dysli2026,
author = {Dysli, Chantal and Sagurski, Nicola and Ferro Desideri, Lorenzo and Zinkernagel, Martin S},
title = {Macular Telangiectasia Type 2: Current and Emerging Diagnostic Imaging Modalities},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2026},
volume = {243},
number = {09},
pages = {901--910},
doi = {10.1055/a-2937-4106}
}
EUVIMED